Ligand validation:6HGF

HCY: (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione

HCY is a Ligand Of Interest in 6HGF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HGF_HCY_B_501	47%	46%	0.136	0.874	1.02	1.06	1	2	0	0	100%	1
6HGG_HCY_A_401	45%	31%	0.131	0.86	1.55	1.22	6	6	1	0	100%	1
6NWL_HCY_A_301	91%	52%	0.068	0.955	0.98	0.89	3	2	3	0	100%	1
6ITP_HCY_B_201	89%	4%	0.076	0.955	4.12	1.7	13	8	1	0	100%	1
5HGC_HCY_A_501	85%	35%	0.11	0.976	0.87	1.69	1	11	0	0	100%	1
8UQF_HCY_B_201	80%	0%	0.084	0.931	6.56	3.27	21	16	14	0	100%	1
8CBY_HCY_H_301	76%	78%	0.095	0.932	0.32	0.57	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.